Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Australia Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20062
20081
20094
20101
20111
20134
20141
20152
20171
20183
20191
20213
20223
20231
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Active, not recruiting8
Terminated7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AstraZeneca3
Novartis Pharmaceuticals3
Pfizer3
AbbVie2
Amgen2
GlaxoSmithKline2
AGO Research GmbH1
Boehringer Ingelheim1
Children's Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms42
Fallopian Tube Neoplasms23
Carcinoma, Ovarian Epithelial10
Peritoneal Neoplasms8
Neoplasms2
Recurrence2
Brain Neoplasms1
Brenner Tumor1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.